EN | RU
EN | RU

Help Support

Back

Presence of secondary fungal and bacterial infections in critically ill COVID-19 patients

Presence of secondary fungal and bacterial infections in critically ill COVID-19 patients Presence of secondary fungal and bacterial infections in critically ill COVID-19 patients
Presence of secondary fungal and bacterial infections in critically ill COVID-19 patients Presence of secondary fungal and bacterial infections in critically ill COVID-19 patients

Patients with severe COVID infection need hospitalization, which makes them more prone to bacterial and fungal infections. This study aimed to describe the incidence of secondary infections and clinical outcomes in critically ill COVID-19 Indian patients.

See All

Key take away

A majority of Gram-negative bacteria in COVID-19 patients were found to be highly resistant to the higher generation of antimicrobial agents.

Background

Patients with severe COVID infection need hospitalization, which makes them more prone to bacterial and fungal infections. This study aimed to describe the incidence of secondary infections and clinical outcomes in critically ill COVID-19 Indian patients.

Method

The presence of secondary infections in hospitalized patients was investigated. The demographic data, infection time following hospital admission, microbiological and antimicrobial resistance data associated with secondary infections, and clinical information of COVID-19 patients were assembled and assessed in this retrospective study, 

Result

About 3.6% of patients out of 17,534 hospitalized COVID patients had secondary bacterial or fungal infections. Death among COVID-19 patients due to nosocomial infections was 56.7% compared to the death of 10.6% of patients in total no. of individuals hospitalized.

Gram-negative bacteria were extracted from 78% of patients, with Klebsiella pneumoniae being the main pathogen, which was followed by Acinetobacter baumannii (21%). Polymicrobial infections (plus fungal infections) was reported by 35% of people. A. Baumannii had high levels of carbapenem resistance (92.6%), which was followed by K. Pneumoniae (72.8%).

Conclusion

In hospitalized coronavirus-infected Indian people, there is a low incidence of bacterial and fungal superinfections. But, the presence of such infections can lead to serious disease with terrible outcomes since most superinfections are due to extremely drug-resistant pathogens and are nosocomial. Therefore, to safeguard patient lives and avoid drug-resistant infections, there is a need for improving infection control practices and antimicrobial stewardship.

Source:

Infection and Drug Resistance

Article:

Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience

Authors:

Sonam Vijay et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: